MENU

Fresh Tracks Therapeutics (FRTX) Ownership - Who owns Fresh Tracks Therapeutics?

Profile

Industry
N/A
Address
2000 Central Avenue
Phone
+1 720 505-4755
Employees
4
Web
https://www.frtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.42M
P/E Ratio
N/A
Total Cash
251K
Projected Growth
N/A
Total Debt
N/A
Revenue
8.01M
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
1.48 USD as % of share price

Fundamentals

FRTX
Capitalization
4.42M
P/E Ratio
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash
251K
Total Cash/Share
0.04
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.48%
Revenue
8.01M
ROE
N/A
Book Value
9.93M
P/B Ratio
0.45
Cash Flow
N/A
Earnings
-1.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
60K
Current Ratio
6.98
Current Revenue Per Employee
611076.94
Dividends Per Share - Security
N/A
EBITDA
-5.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
-77.15
Revenue To Assets
-52.10
Shares Held By Institutions
84
Shares Outstanding - Current
5.97M
Total Liabilities
1.66M
Total Volume MTD
N/A
Value
1
Gain YTD
-15.823
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Central Avenue
Phone
+1 720 505-4755
Employees
4
Web
https://www.frtx.com